Cargando…

Treating diabetic dyslipidemia: What have we learnt from recent clinical trials?

Detalles Bibliográficos
Autor principal: Tan, Kathryn CB
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014884/
https://www.ncbi.nlm.nih.gov/pubmed/24843436
http://dx.doi.org/10.1111/j.2040-1124.2010.00058.x
_version_ 1782315250505220096
author Tan, Kathryn CB
author_facet Tan, Kathryn CB
author_sort Tan, Kathryn CB
collection PubMed
description
format Online
Article
Text
id pubmed-4014884
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-40148842014-05-19 Treating diabetic dyslipidemia: What have we learnt from recent clinical trials? Tan, Kathryn CB J Diabetes Investig Editorial Blackwell Publishing Ltd 2010-12-03 2010-12-03 /pmc/articles/PMC4014884/ /pubmed/24843436 http://dx.doi.org/10.1111/j.2040-1124.2010.00058.x Text en © 2010 Asian Association for the Study of Diabetes and Blackwell Publishing Asia Pty Ltd
spellingShingle Editorial
Tan, Kathryn CB
Treating diabetic dyslipidemia: What have we learnt from recent clinical trials?
title Treating diabetic dyslipidemia: What have we learnt from recent clinical trials?
title_full Treating diabetic dyslipidemia: What have we learnt from recent clinical trials?
title_fullStr Treating diabetic dyslipidemia: What have we learnt from recent clinical trials?
title_full_unstemmed Treating diabetic dyslipidemia: What have we learnt from recent clinical trials?
title_short Treating diabetic dyslipidemia: What have we learnt from recent clinical trials?
title_sort treating diabetic dyslipidemia: what have we learnt from recent clinical trials?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014884/
https://www.ncbi.nlm.nih.gov/pubmed/24843436
http://dx.doi.org/10.1111/j.2040-1124.2010.00058.x
work_keys_str_mv AT tankathryncb treatingdiabeticdyslipidemiawhathavewelearntfromrecentclinicaltrials